Heart Failure, Risk Factor, Cardiovascular
Conditions
Keywords
heart failure, risk factor, cardiovascular disease, lifestyle behavior
Brief summary
This is an prospective study conducted in a Chinese heart failure population. The study investigates the effects of cardiovascular disease risk factors such as lifestyle behaviors,biomarkers and intermediate diseases on heart failure prognosis.
Detailed description
Heart failure is the main cause of cardiovascular death. The primary goal of this study is to estimate the association of lifestyle behavior (e.g., alcohol, tea and coffee consumption, sedentary behavior, smoking habit, sleep disorder and physical activity), intermediate conditions (e.g., hypertension, diabetes and dyslipidemia), genetic risk factors and circulating biomarkers with heart failure prognosis. Another goal is to improve the health status and reduce cardiovascular events and death for heart failure patients via patient education, disease monitoring and medication titration. This study planned to consecutively enroll 1,000 heart failure patients fulfilling the inclusion criteria. Each participants will be followed up for at least 5 years. The study endpoints, all-cause mortality and cardiovascular events, will be identified by directly contacting participants during the follow-up surveys, checking pertinent medical records and discharge lists from the hospitals, or checking death certificates from local vital statistics offices. The Cox proportional hazard model will be used to estimate the risk factors for health outcomes in heart failure patients.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* aged 18 and above * inpatient with one of the following clinical situations: * congestive heart failure (pulmonary edema,pulmonary congestion or peripheral edema) * cardiogenic shock * Insufficient high output cardiac * with impaired cardiac function diagnosed by echocardiography * able to provide informed consent
Exclusion criteria
* expressed refusal to participate in the baseline investigation or follow-up visits Severe co-morbidity associated with a reduction in life expectancy of less than 12 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| All-cause mortality | 10 years | — |
| A composite of cardiovascular events | 10 years | A composite of myocardial infarction, revascularization, stroke, rehospitalization due to heart failure and cardiovascular death |
Secondary
| Measure | Time frame |
|---|---|
| stroke | 10 years |
| myocardial infarction | 10 years |
| cardiovascular death | 10 years |
| rehospitalization due to heart failure | 10 years |
| revascularization | 10 years |
Countries
China